Highlights
- •First report of a missense DLX3 variant in an Iranian family with myomas and pregnancy losses.
- •First identified likely pathogenic DLX3 variant in N-term transactivation domain.
- •Segregation of the variant with disease within the family.
- •Prediction of damaging activity of the variant by physico-chemical parameters analysis.
- •Mini-review on the role of DLX3 in embryonic development and DLX3-associated syndromes.
https://www.sciencedirect.com/science/article/abs/pii/S0378111923001336
